USC researchers begin tests on next generation of retinal implant

Feb 16, 2007

Patients who have gone blind are a step closer to perhaps one day regaining some of their sight. Researchers at the University of Southern California, Doheny Eye Institute, announced today the next step in their efforts to advance technology that will hopefully help patients with retinitis pigmentosa and macular degeneration regain some vision using an implanted artificial retina.

The announcement by Mark Humayun, M.D., Ph.D., professor of ophthalmology at the Doheny Eye Institute, Keck School of Medicine of USC came at a press conference at the American Association for the Advancement of Science (AAAS) annual meeting in San Francisco.

The Food and Drug Administration (FDA) recently approved an Investigational Device Exemption (IDE) to conduct a clinical study of the new device- dubbed the Argus II Retinal Prosthesis System.

The implantable technology is a collaborative effort between USC and Second Sight Medical Products, which manufactures the implant. The Argus II is the second generation of an electronic retinal implant designed for the treatment of blindness due to retinitis pigmentosa (RP), a group of inherited eye diseases that affect the retina. RP causes the degeneration of photoreceptor cells in the retina, which capture and process light helping individuals to see. As these cells degenerate, patients experience progressive vision loss. The Argus device is essentially designed to take the place of the photoreceptors.

"The first phase of our implant work began in 2002," says Humayun. "We have successfully implanted six patients in the trial and we have found that the devices are indeed electrically conducting and can be used by patients to detect light or even to distinguish between objects such as a cup or plate."

While the first generation of implants contained 16 electrodes laid out on an array, the Argus II is designed with 60 electrodes, which is intended to allow for higher resolution images.

The new device is also approximately one quarter the size of the original, reducing surgery and recovery times.

The array is attached to the retina and used in conjunction with an external camera and video processing system to provide a rudimentary form of sight to implanted subjects.

The clinical trial of the first generation of implants continues at the Doheny Eye Institute at USC. All six previously blind patients in the first trial have been able to detect light, identify objects in their environment and even perceive motion after implantation with the first generation device.

The device, ultimately, may be used for the millions of people suffering from age-related macular degeneration, or AMD. In fact, Humayun says, there are 25 million people around the world, including 6 million in the United States alone, who have been blinded, or are severely visually impaired, due to diseases like RP and AMD.

By 2020, that figure is expected to double, creating a virtual vision-loss epidemic.

Both AMD and RP destroy vision by annihilating the retinal cells that allow light to be translated into recognizable images.

"Perhaps what we're most excited about in this next study," says Humayun, "is, similar to the first generation Second Sight device, we will be able to test the new device with patients at their homes, churches, schools and similar locations. The importance of this work is going to be reflected in how well this helps them regain some of their lost vision."

The current study will include patients over 50 years of age who have RP or AMD and who have had previous functional vision.

Source: University of Southern California

Explore further: Systemic sclerosis patients with unhealed digital ulcers benefit from fat cell transplant

add to favorites email to friend print save as pdf

Related Stories

Image sensors that behave like biological retinas

Feb 18, 2015

Ever since the invention of the first camera obscura and the advent of photography in the 19th century, scientists have been fascinated by the use of light sensors to capture the world around us from the ...

Lab-in-a-box takes aim at doctors' computer activity

Feb 12, 2015

They call it "the Lab-in-a-Box." According to Nadir Weibel, a research scientist in the Computer Science and Engineering (CSE) department at the University of California, San Diego, inside the box are assorted ...

Developing radically new technologies for X-ray systems

Feb 04, 2015

Siemens is investigating entirely new concepts for X-ray systems. The aim is to achieve a radical increase in imaging resolution and to enable phase-contrast X-ray imaging. This entirely new technique helps, ...

Rapid test kit detects dengue antibodies from saliva

Jan 29, 2015

Finding out whether you have been infected with dengue may soon be as easy as spitting into a rapid test kit. The Institute of Bioengineering and Nanotechnology (IBN) of A*STAR has developed a paper-based ...

Wireless charging system on cusp of commercialization

Jan 21, 2015

Imagine a world where you don't have to plug in your smartphone, tablet or laptop, or even lay it on one of the Duracell charging mats that Starbucks is rolling out nationwide. Instead, your refrigerator sends them power ...

Recommended for you

Longer needles recommended for epinephrine autoinjectors

3 hours ago

(HealthDay)—Given the increasing epidemic of obesity, epinephrine autoinjectors (EAIs) for anaphylaxis require longer needles to ensure intramuscular injection, according to a study published online Feb. ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.